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Background: With the introduction of ICD-10 throughout Canada, it is important to ensure that
Acute Myocardial Infarction (AMI) comorbidities employed in risk adjustment methods remain
valid and robust. Therefore, we developed ICD-10 coding algorithms for nine AMI comorbidities,
examined the validity of the ICD-10 and ICD-9 coding algorithms in detection of these
comorbidities, and assessed their performance in predicting mortality. The nine comorbidities that
we examined were shock, diabetes with complications, congestive heart failure, cancer,
cerebrovascular disease, pulmonary edema, acute renal failure, chronic renal failure, and cardiac
dysrhythmias.
Methods: Coders generated a comprehensive list of ICD-10 codes corresponding to each AMI
comorbidity. Physicians independently reviewed and determined the clinical relevance of each item
on the list. To ensure that the newly developed ICD-10 coding algorithms were valid in recording
comorbidities, medical charts were reviewed. After assessing ICD-10 algorithms' validity, both
ICD-10 and ICD-9 algorithms were applied to a Canadian provincial hospital discharge database to
predict in-hospital, 30-day, and 1-year mortality.
Results: Compared to chart review data as a 'criterion standard', ICD-9 and ICD-10 data had
similar sensitivities (ranging from 7.1 – 100%), and specificities (above 93.6%) for each of the nine
AMI comorbidities studied. The frequencies for the comorbidities were similar between ICD-9 and
ICD-10 coding algorithms for 49,861 AMI patients in a Canadian province during 1994 – 2004. The
C-statistics for predicting 30-day and 1 year mortality were the same for ICD-9 (0.82) and for ICD-
10 data (0.81).
Conclusion: The ICD-10 coding algorithms developed in this study to define AMI comorbidities
performed similarly as past ICD-9 coding algorithms in detecting conditions and risk-adjustment in
our sample. However, the ICD-10 coding algorithms should be further validated in external
databases.
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Background
Acute myocardial infarction (AMI) outcomes are studied
frequently in health service research with hospital dis-
charge administrative data [1-8]. Risk adjustment is an
important tool used in health service research to account
for differences in AMI patient's characteristics. To develop
such a tool for AMI patients, Tu et al. [3] initially selected
43 comorbidities that were used as potential risk factors
for AMI in United States hospital report cards. The nine
comorbidities were chosen from the 43 comorbidities
based on their clinical plausibility and statistical signifi-
cance. Along with adjustments for sex and age, these 9
comorbidities were found to substantially predict AMI
mortality in Ontario provincial database, and were vali-
dated in 2 external databases from Manitoba, Canada and
California, the United States. Subsequently, many studies
have assessed its validity and employed the AMI predic-
tion method [4,5,9-21]. Grunau et al. compared Tu et al's
disease specific prediction rule to many other methods
[20]. These authors found that Tu's method performed
better than other general methods that summarized
comorbidities as a score, or included comorbidities that
are less relevant for AMI outcomes. Hence, Canada has
accepted Tu's risk adjustment method to generate public
reports of AMI outcomes [21].
With the introduction of tenth revision of the Interna-
tional Classification of Disease (ICD-10) coding system
by the World Health Organization (WHO) [22] in 1992,
this risk adjustment tool may no longer be valid. ICD-10
is significantly different from ICD-9 coding system, differ-
ing in the richness of clinical information and use of
alphanumeric codes relative to numeric codes in ICD-9.
Hence, previously validated [23] ICD-9 coding algorithms
used for the nine comorbidities cannot be applied to the
new ICD-10 data. Without valid ICD-10 coding algo-
rithms, administrative data can not be used to measure
and control for patients' comorbidities when studying
their clinical outcomes. Further, future policy and quality
decisions using ICD-10 data require the development and
validation of ICD-10 coding algorithms for these comor-
bidities.
The objective of this study was to develop ICD-10 coding
algorithms for the nine AMI comorbidities. The validity of
these newly developed ICD-10 algorithms was deter-
mined by reviewing medical charts in recording AMI
comorbidities. We then applied the ICD-10 and past ICD-
9 coding algorithms to administrative data from a large
Canadian province. Comparisons between the two coding
algorithms were made by comparing their performance in
predicting in-hospital, 30-day, and 1-year AMI mortality.
Methods
Development of ICD-10 Coding Algorithm
A three step process was employed to develop the ICD-10
coding algorithms for the nine AMI comorbidities, which
include shock, diabetes with complications, congestive
heart failure, cancer, cerebrovascular disease, pulmonary
edema, acute renal failure, chronic renal failure, and car-
diac dysrhythmias [3]. In the first step, the ICD-10 Cana-
dian computerized code finder was used to generate a list
of all relevant ICD-10 codes, matching to clinical terms of
the comorbidities. Two coders trained in both ICD-9 and
ICD-10 coding systems independently generated separate
lists, which were then compared to form a single list of
ICD-10 codes. A physician was consulted for the disagree-
ments between the two coders on the codes.
In the second step, ICD-9-CM coding descriptions from
the ICD-9-CM manual were used to generate a list of
matching ICD-10 codes. Again, each coder independently
generated a list of ICD-10 codes, which then were com-
pared to form a single list. This second list was merged
with the list from step one to form a comprehensive ICD-
10 code list. In the third step, four physicians independ-
ently reviewed this list, and then met to determine
whether each coding algorithm met the clinical meaning
based on their experiences. The four physicians are spe-
cialists in neurology, general internal medicine, and psy-
chiatry. For the disagreements about the codes on the list,
an additional physician was consulted to finalize the list
of coding algorithms for the nine comorbidities.
Alberta Chart Review data
A simple random sample from four teaching hospitals
was used to select 4,008 patients' charts to be reviewed.
These records were patients who were discharged between
July and December 2003 in the province of Alberta, Can-
ada. In this study period, hospital discharge data were
coded in ICD-10. Two reviewers with coding and medical
training reviewed the charts and determined the presence
of the nine comorbidities. Moreover, the charts were re-
coded by regular health record coding staff in ICD-9 to
create a 'real world ICD-9 dataset'. Therefore, three data-
bases were generated for the same charts, including the
originally coded ICD-10 data, chart review data and re-
coded ICD-9 data. Of these 4,008 records, there were 193
patients with AMI, based on their chart information. We
included these 193 patients for assessment of validity of
ICD-9 and ICD-10 data in recording the nine comorbidi-
ties.
ICD-9 and ICD-10 Administrative Data
We used hospital discharge abstract data from 1994 to
2004 fiscal year from the province of British Columbia,
Canada. This administrative data was coded in ICD-9
between 1994 and 2000 fiscal year, and then was coded inBMC Health Services Research 2006, 6:161 http://www.biomedcentral.com/1472-6963/6/161
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ICD-10 between 2001 and 2004 fiscal year. To define AMI
patients, we abstracted patients with the most responsible
diagnosis field coded as 410.x in the ICD-9 data and I21.x
and/or I22.x in ICD-10 data. In addition, we kept all
patients with coronary artery disease (those with the most
responsible diagnosis field coded as 414.0 in ICD-9 and
I25.1 in ICD-10), AMI (the secondary diagnosis fields
coded as 410.x in the ICD-9 data and I21.x and/or I22.x in
ICD-10 data) and underwent coronary angioplasty or
bypass graft surgery (48.1, 48.02, 48.03 of Canadian Clas-
sification of Procedure (CCP) [24] for ICD-9 data and
1IJ76 of Canadian Classification of Intervention (CCI)
[25] for ICD-10), but excluded patients who underwent
heart valvuloplasty surgeries (47.1 and 47.2 of CCP for
ICD-9 and 1HV80, 1HU80, 1HT80, 1HS80, 1HS90,
1HT90, 1HU90, 1HV90 of CCI for ICD-10 data). Further-
more, we excluded AMI patients with the exclusion crite-
ria: 1. not a British Columbia resident, 2. age less than 20
years, and 3. length of hospital stay less than or equal to
one day. Patients who are discharged on the same day of
the admission or the following day were excluded to
remove emergency room deaths and to improve the accu-
racy of AMI diagnosis. After excluding patients meeting
these criteria, patients were sorted by their earliest AMI
admission. Admissions following the earliest admission
or admissions in 1994 were excluded. Finally, these AMI
patients were linked with British Columbia vital statistics
to determine deaths after discharge.
Statistical Analysis
In order to validate the ICD-9 and ICD-10 coding algo-
rithm, we compared ICD-9 and ICD-10 data with chart
review data in defining comorbidities. Chart review data
was used as a 'criterion standard'. Sensitivity, specificity,
positive predictive value (PPV) and negative predictive
value (NPV) statistics were calculated for comorbidities in
ICD-9 and ICD-10 data.
After validating the ICD-9 and ICD-10 coding algorithms,
we applied them to British Columbia's administrative
data and produced descriptive statistics for the study pop-
ulation. Logistic regressions were used to predict AMI
mortality with ICD-9 and ICD-10 coded comorbidities.
An alternative modeling approach is to use a Cox regres-
sion to account for the risk of mortality over time. How-
ever, logistic regression was used to predict mortality in
the fixed period. This approach has been commonly used
in previous studies. Therefore, comparability of our study
to previous studies could be increased by using the logistic
regression approach. Using the above nine comorbidities
and the study populations' age and sex, we predicted in-
hospital, 30-day and 1-year AMI mortality. Each OR
should be interpreted as controlling for all nine comor-
bidities, age and sex. No model building strategy was
employed because this 11 variable prediction rule had
been validated by Tu et al's study and referenced subse-
quently by studies using this prediction rule [4,5,9-21].
The regressions between ICD-9 and ICD-10 coded comor-
bidities were evaluated by comparing their C-statistics,
Brier Scores, and R-squares. A C-statistic evaluates each
model's ability to discriminate deceased from alive
patients by comparing the observed to predicted values. A
C-statistic equal to 0.5 indicates random prediction, while
a value of one indicates perfect prediction [26]. If the C-
statistics generated from ICD-9 regressions are similar to
the C-statistics from ICD-10 regressions, then we could
infer that ICD-10 coded comorbidities perform compara-
bly to ICD-9 coded comorbidities. Another measure we
used to assess the models' predicted probabilities was the
Brier score. The Brier score measures the mean squared
difference between expected probability of dying and its
actual occurrence [27]. Low Brier scores indicate that there
is a small difference, which shows that the model pre-
dicted well. The R-square summary statistic is used to
assess how well the model fits with the data. In particular,
R-square measures the proportion of the total variation in
mortality explained by the logistic regression model.
Results
Agreement between Administrative Data and Chart 
Review Data
Table 1 shows ICD-9 and 10 coding algorithms for defin-
ing the nine comorbidities. The comparison of ICD-9 and
our ICD-10 coding algorithms and medical charts is
shown in Table 2. Frequencies for six AMI comorbidities
were similar among ICD-9, ICD-10 and chart review data.
Three comorbidities, i.e. cerebrovascular disease, pulmo-
nary edema and cardia dysrhythmias had similar frequen-
cies between ICD-9 and ICD-10 data, but lower
frequencies compared with chart review data. Each
comorbidity recorded in ICD-9 and ICD-10 datasets was
very similar in sensitivity, specificity, PPV and NPV (see
Table 3). However, the validity varied across comorbidi-
ties in both datasets. Sensitivities ranged from 7.1–100%
and PPVs ranged from 33.3–100% in both ICD-9 and
ICD-10 data, respectively. Specificity for all comorbidities
was higher than 93% in both datasets. NPV was low for
cardiac dysrhythmias (56.1% in ICD-9 and 55.6% in ICD-
10 data) and higher than 86% for the remaining eight
comorbidities. The width of the 95% confidence intervals
for the nine comorbidities shows the low prevalence for
most of the comorbidities in the chart review data except
for cardiac dysrhythmias and congestive heart failure.
Frequency and Mortality in Administrative Data
Given the similarity to chart review data for the majority
of ICD-9 and ICD-10 coded comorbidities, we applied the
coding algorithms to hospital discharge abstract dataset.
There were 29,610 AMI cases in ICD-9 dataset (1995–BMC Health Services Research 2006, 6:161 http://www.biomedcentral.com/1472-6963/6/161
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2000 fiscal years) and 20,251 in ICD-10 dataset (2001–
2004 fiscal years). The frequencies for age, gender and
comorbidities were similar between the two datasets (see
Table 4). Patients were predominantly male (approxi-
mately 66%) and older than 50 years old (approximately
90%). Congestive heart failure and cardiac dysrhythmias
were the two most prevalent comorbidities, while pulmo-
nary edema was the least prevalent comorbidity. The
absolute difference in the frequencies between ICD-9 and
ICD-10 coded comorbidities was less than 2%.
The in-hospital, 30-day, and 1-year mortality rates for the
AMI patients were 8.5%, 9.9%, and 16.5% in ICD-9 data
and 6.8%, 9.0% and 16.4% in ICD-10 data, respectively.
Comorbidity specific mortality rates between the two
datasets revealed a similarity (see Table 5). Shock and
acute renal failure had high mortality. The absolute differ-
ence in in-hospital, 30-day and 1-year mortality rates
between the two datasets differed less than 10% for 8
comorbidities and acute renal failure had an absolute dif-
ference of 16.0% for in-hospital mortality rate.
Predicting Mortality in Administrative Data
The ability of the ICD-10 regression to discriminate
between those deceased or alive was similar to the ICD-9
regression's ability, as shown by the C-statistics in Table 6.
The C-statistics only varied between 0.81 and 0.83 for pre-
dicting in-hospital, 30-day, and 1-year mortality. Moreo-
ver, the odds ratios estimated by the ICD-9 and ICD-10
regressions showed similar model performance between
the two datasets. The same result was observed when com-
paring the Brier scores between ICD-9 and ICD-10 regres-
sions. The lower Brier scores for ICD-10 regressions
relative to ICD-9 regression indicated that it performed
slightly better than the ICD-9 regressions. Both ICD-9 and
ICD-10 models explained approximately 20 percent of
the variation in mortality, as shown by the R-squares in
Table 6. The small difference between ICD-9 and ICD-10
models' R-squares shows again the similarity between the
two coding systems.
All the regressions showed that patients who were 75
years or older were the most likely to die, relative to other
Table 2: Prevalence of comorbidity in Alberta chart review data, ICD-9, and ICD-10 data among AMI patients (N = 193)
Comorbidities Chart Review ICD-9 Data ICD-10 Data
N % of 193 N % of 193 N % of 193
Shock 5 (2.6) 5 (2.6) 4 (2.1)
Diabetes with Complications 15 (7.8) 15 (7.8) 12 (6.2)
Congestive Heart Failure 55 (28.5) 50 (25.9) 47 (24.4)
Cancer 10 (5.2) 10 (5.2) 12 (6.2)
Cerebrovascular disease 6 (3.1) 6 (3.1) 6 (3.1)
Pulmonary Edema 28 (14.5) 2 (1.0) 2 (1.0)
Acute Renal Failure 15 (7.8) 15 (7.8) 20 (10.4)
Chronic Renal Failure 18 (9.3) 22 (11.4) 16 (8.3)
Cardiac Dysrhythmias 106 (54.9) 33 (17.1) 40 (20.7)
Table 1: ICD-9 and ICD-10 Codes for AMI Comorbidities
Comorbidities ICD-9* ICD-10
Acute Myocardial Infarction 410.x I21.x
Shock 785.5 R57
Diabetes with Complications 250.1–250.9 E10.0 – E10.8, E11.0 – E11.8, E12.0 – E12.8, 
E13.0 – E13.8, E14.0 – E14.8
Congestive Heart Failure 428.x I09.9, I11.0, I13.0, I13.2, I25.5, I42.0, I42.5 – 
I42.9, I43.x, I50.x, P29.0
Cancer 140.0–208.9 C00.x–C97.x
Cerebrovascular disease 430.x–438.x G45.x G46.x, H34.0, I60.x – I69.x
Pulmonary Edema 518.4, 514.x J18.2, J81.x
Acute Renal Failure 584.x, 586.x, 788.5 N17.x, N19.x, R34.x
Chronic Renal Failure 585.x, 403.x, 404.x, 996.7, v451 N18.x, T82.4, Z49.2, Z99.2
Cardiac Dysrhythmias 427.x I44.1–I44.3, I45.6, I45.9, I46.x, I47.x, I48.x, 
I49.x, R00.0, R00.1, R00.8, T82.1, Z45.0, Z95.0
*Note: ICD-9 codes are from Tu et al.[3]BMC Health Services Research 2006, 6:161 http://www.biomedcentral.com/1472-6963/6/161
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age groups. The interpretation of the odds ratio for the
gender variable differed across ICD-9 and ICD-10 regres-
sions. For ICD-9 regressions, male patients were less likely
to die than female patients, while the opposite result was
found for ICD-10 regressions. Of the nine comorbidities,
shock variable had the largest odds ratios in predicting in-
hospital and 30-day mortality. The absolute difference in
odds ratio between the two datasets was marginal for the
comorbidities, differing by approximately 2%. All comor-
bidities were statistically significant at the 95% confidence
level except for diabetes with complications in predicting
30-day mortality in ICD-10 data.
Discussion
We developed the ICD-10 coding algorithms to define
nine comorbidities used to adjust risk factors in AMI out-
come studies. The newly developed ICD-10 coding algo-
rithms were comparable with previously published and
widely used ICD-9 coding algorithms in detection of cases
and predicting mortality. We also know that the ICD-9
and 10 data had similar validity in recording the nine
comorbidities when compared to chart review data.
The similar sensitivity, specificity, PPV and NPV found for
the ICD-9 and ICD-10 coding algorithms when referenced
to the chart review data suggests that both are similarly
accurate in recording AMI comorbidities. However, both
ICD-9 and ICD-10 datasets matched poorly to the chart
review data for pulmonary edema, cardiac dysrhythmias,
and cerebrovascular disease. The low sensitivities for pul-
monary edema and cardiac dysrhythmias were likely due
to the ambiguity of their diagnoses and/or being symp-
toms of underlying conditions [1,28-30]. In contrast to
comorbidities that are well documented, such as cancer,
physicians may document non-specific conditions or
symptoms poorly in charts. Therefore, it is difficult for
coders to make definitive decisions on the presence of
these types of conditions based on the chart information,
which can result in coding errors. The low positive predic-
tive value for cerebrovascular disease is partly due to the
low prevalence. Further, Benesch et al. [31] found a third
of asymptomatic patients coded in ICD-9-CM as having
cerebrovascular diseases, but found no evidence of occlu-
sion or stenosis of the precerebral arteries [31]. Kokotailo
and Hill [32] found that there was a range of coding errors
for cerebrovascular disease, where transient ischemic
attack (TIA) was coded for acute ischemic stroke. The dif-
ficulty with coding TIA was that the symptoms were non-
specific, arising from many other conditions besides a
temporary disruption in blood flow to a part of the brain
[33]. Nevertheless, the similarity in misclassification by
ICD-9 and ICD-10 coding algorithms for these three
comorbidities suggests that risk-adjustment with the AMI
nine comorbidities will not be affected by the change in
coding system from ICD-9 to ICD-10.
When we applied the ICD-10 coding algorithms to the
hospital discharge data, we found similarities across fre-
quencies, mortality rates, and overall model performance
to ICD-9 coding algorithms. This result suggests that the
ICD-10 coding algorithms for these nine comorbidities
performed similarly to past ICD-9 coding algorithms. This
inference was further supported by the similar results
found in our study and the study conducted by Tu et al.
Table 3: Agreement between ICD-9/ICD-10 and Alberta chart review data among AMI patients (N = 193)
Comorbidities ICD-9 Data ICD-10 Data
Sensitivity Specificity PPV NPV Sensitivity Specificity PPV NPV
Shock 60.0 98.9 60.0 98.9 60.0 99.5 75.0 98.9
(95% CI) (14.66 – 94.73) (96.21 – 99.87) (14.66 – 94.73) (96.21 – 99.87) (14.66 – 94.73) (97.07 – 99.99) (19.41 – 99.37) (96.23 – 99.87)
Diabetes with 
Complications
80.0 98.3 80.0 98.3 66.7 98.9 83.3 97.2
(95% CI) (51.91 – 95.67) (95.15 – 99.65) (51.91 – 95.67) (95.15 – 99.65) (38.38 – 88.18) (96.00 – 99.86) (51.59 – 97.91) (93.67 – 99.10)
Congestive Heart 
Failure
81.8 96.4 90.0 93.0 80.0 97.8 93.6 92.5
(95% CI) (69.10 – 0.92) (91.75 – 98.81) (78.19 – 96.67) (87.52 – 96.60) (67.03 – 89.57) (93.78 – 99.55) (82.46 – 98.66) (86.92 – 96.18)
Cancer 90.0 99.5 90.0 99.5 90.0 98.4 75.0 99.4
(95% CI) (55.50 – 99.75) (96.99 – 99.99) (55.50 – 99.75) (96.99 – 99.99) (55.50 – 99.75) (95.28 – 99.66) (42.81 – 94.51) (96.96 – 99.99)
Cerebrovascular 
disease
100.0 93.6 33.3 100.0 100.0 95.7 42.9 100.0
(95% CI) (54.07 – 100.00) (89.06 – 96.64) (13.34 – 59.01) (97.91 – 100.00) (54.07 – 100.00) (91.74 – 98.14) (17.66 – 71.14) (97.96 – 100.00)
Pulmonary Edema 7.1 100.0 100.0 86.4 7.1 100.0 100.0 86.4
(95% CI) (0.88 – 23.50) (97.79 – 100.00) (15.81 – 100.00) (80.69 – 90.91) (0.88 – 23.50) (97.79 – 100.00) (15.81 – 100.00) (80.69 – 90.91)
Acute Renal 
Failure
80.0 98.3 80.0 98.3 80.0 95.5 60.0 98.3
(95% CI) (51.91 – 95.67) (95.15 – 99.65) (51.91 – 95.67) (95.15 – 99.65) (51.91 – 95.67) (91.34 – 98.04) (36.05 – 80.88) (95.02 – 99.64)
Chronic Renal 
Failure
83.3 96.0 68.2 98.2 72.2 98.3 81.3 97.2
(95% CI) (58.58 – 96.42) (91.93 – 98.38) (45.13 – 86.14) (94.96 – 99.64) (46.52 – 90.31) (95.07 – 99.65) (54.35 – 95.95) (93.53 – 99.08)
Cardiac 
Dysrhythmias
35.9 100.0 100.0 56.1 35.8 97.7 95.0 55.6
(95% CI) (26.77 – 45.74) (95.85 – 100.00) (90.75 – 100.00) (47.94 – 64.08) (26.77 – 45.74) (91.94 – 99.72) (83.08 – 99.39) (47.31 – 63.58)BMC Health Services Research 2006, 6:161 http://www.biomedcentral.com/1472-6963/6/161
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[3] Both studies found that the two most prevalent comor-
bidities were congestive heart failure and cardiac dys-
rhythmias, and the least prevalent comorbidity was
pulmonary edema [3]. This similarity between the two
studies was also shown by the overall model perform-
ances. Tu et al's 0.78 and 0.79 C-statistics for their 30-day
and 1-year mortality logistic regressions, respectively
matched closely to the 0.81 C-statistic we found in pre-
dicting for both mortality rates for our ICD-10 data [3].
Comparing our odds ratios to Tu et al.'s findings, we both
found that patients with shock and acute renal failure
tended to have the highest likelihoods of dying [3].













N % of 29610 N % of 20251 N % of 29610 N % of 20251 N % of 29610 N % of 20251
Overall 2384 8.1 1386 6.8 2943 9.9 1824 9.0 4899 16.5 3311 16.3
Age
20 – 49 26 0.9 23 1.2 38 1.3 29 1.5 64 2.3 46 2.4
50 – 64 194 2.4 100 1.8 260 3.2 152 2.8 449 5.5 271 4.9
65 – 74 501 6.1 203 4.2 659 8.1 292 6.1 1108 13.6 548 11.4
>=75 1663 15.9 1060 13.1 1986 18.9 1351 16.8 3278 31.3 2446 30.3
Gender
Female 1136 11.6 580 8.3 1343 13.7 754 10.8 2139 21.8 1401 20.1
Male 1248 6.3 806 6.1 1600 8.1 1070 8.1 2760 13.9 1910 14.4
Comorbidities
Shock 394 52.6 173 47.3 407 54.3 178 48.6 438 58.5 194 53.0
Diabetes with Complications 80 15.7 71 13.3 94 18.4 83 15.5 167 32.7 166 31.0
Congestive Heart Failure 1205 19.1 665 16.8 1435 22.7 856 21.6 2378 37.6 1501 37.9
Cancer 91 17.8 70 19.3 109 21.3 103 28.5 230 44.9 202 55.8
Cerebrovascular disease 267 26.0 130 25.5 293 28.5 149 29.2 424 41.3 209 41.0
Pulmonary Edema 50 26.6 25 21.0 56 29.8 33 27.7 81 43.1 53 44.5
Acute Renal Failure 298 47.2 224 31.1 307 48.6 253 35.1 380 60.1 358 49.7
Chronic Renal Failure 167 21.3 122 17.6 184 23.5 167 24.0 310 39.6 308 44.3
Cardiac Dysrhythmias 940 17.0 506 14.5 1057 19.1 596 17.1 1588 28.7 972 27.9
Note: Both ICD-9 and ICD-10 data excluded all patients who were discharged on the same day of admission or the following day
Table 4: Prevalence of comorbidities among AMI patients (%)
Variables ICD-9 Data ICD-10 Data
N (% of 29610) N (% of 20251)
Age
20 – 49 2835 (9.6) 1895 (9.4)
50 – 64 8136 (27.5) 5499 (27.2)
65 – 74 8151 (27.5) 4793 (23.7)
>=75 10488 (35.4) 8064 (39.8)
Gender
Female 9812 (33.1) 6976 (34.4)
Male 19798 (66.9) 13275 (65.6)
Comorbidities
Shock 749 (2.5) 366 (1.8)
Diabetes with 
Complications
510 (1.7) 535 (2.6)
Congestive Heart Failure 6319 (21.3) 3963 (19.6)
Cancer 512 (1.7) 362 (1.8)
Cerebrovascular Disease 1027 (3.5) 510 (2.5)
Pulmonary Edema 188 (0.6) 119 (0.6)
Acute Renal Failure 632 (2.1) 720 (3.6)
Chronic Renal Failure 783 (2.6) 695 (3.4)
Cardiac Dysrhythmias 5540 (18.7) 3478 (17.2)BMC Health Services Research 2006, 6:161 http://www.biomedcentral.com/1472-6963/6/161
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This study had some limitations. The first limitation was
low frequencies for comorbidities in the chart review data,
making it difficult to draw inferences to a broader popula-
tion. Secondly, having chart review data from only teach-
ing hospitals might generate a non-random sample, as it
might have fewer healthy patients than a sample that
included patients from non-teaching hospitals. Evidence
of this result can be seen by the higher frequencies in the
comorbidities in the Alberta chart review data relative to
British Columbia discharge abstract data. Thirdly, gather-
ing chart review data from the first year ICD-10 was imple-
mented might result in a sample with high coding error.
Fourthly, possible provincial and temporal changes in the
occurrence of AMI, mortality, and comorbidities were not
controlled. In the 10 year period, the criteria for AMI diag-
nosis were revised and efficient treatment to chronic dis-
ease was produced. For example, biomarkers of cardiac
troponin and creatinine kinase-MB mass were included in
diagnosis of myocardial infarction to increase sensitivity
and specificity [34]. The advances in disease treatment
and management can partly explain the slight variation
between ICD-9 and ICD-10 models that can not be
accounted for in our analysis. Fifthly, we excluded
patients who were discharged on the day of admission or
the following day. The limitation of this exclusion is that
some true AMI cases were excluded. We re-analyzed our
data after including deaths within 1 day. Including the
3,049 deaths within one day produced a decrease in the C-
statistics for all our models. This suggests that the C-statis-
tics reported in our study are slightly overestimated. Nev-
ertheless, there remains a small difference between the
predictive ability of ICD-9 and ICD-10 models. Lastly, the
proportion of AMI patients that could not be linked with
vital death registry or had moved out of the BC province
without notice to the population registry during our study
period were lost to follow-up. According to Li et al. (35),
the accuracy of linkage between the registry file and inpa-
tient discharge dataset was about 98%. We also suspect
that only a few AMI patients moved out of the BC prov-
ince given that our longest period of observing mortality
was one year. Hence, our results were less likely affected
by this small proportion of AMI patients lost to follow-up.
Conclusion
The ICD-10 coding algorithms for AMI comorbidities pro-
duced in this study generated comparable results to past
ICD-9 coding algorithms. This result was evident when
ICD-9 and ICD-10 comorbidities were similar in frequen-
cies and model performance. A step we took to ensure that
not only did ICD-10 coding definitions matched well to
past ICD-9 coding definitions, but also to a criterion
standard, chart review data. The results from this step













Variables OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Age
20 – 49 1.0 (1.0–1.0) 1.0 (1.0–1.0) 1.0 (1.0–1.0) 1.0 (1.0–1.0) 1.0 (1.0–1.0) 1.0 (1.0–1.0)
50 – 64 2.1 (1.4–3.2) 1.1 (0.7–1.8) 2.0 (1.5–2.8) 1.5 (1.0–2.2) 2.1 (1.6–2.8) 1.7 (1.3–2.4)
65 – 74 4.4 (2.9–6.7) 2.3 (1.5–3.6) 4.3 (3.1–6.1) 2.8 (1.9–4.2) 4.6 (3.5–5.9) 3.6 (2.7–5.0)
>=75 11.4 (7.6–17.14) 7.5 (4.9–11.6) 10.1 (7.2–14.1) 8.0 (5.5–11.7) 11.6 (9.0–15.0) 11.0 (8.1–14.9)
Gender
Female 1.0 (1.0–1.0) 1.0 (1.0–1.0) 1.0 (1.0–1.0) 1.0 (1.0–1.0) 1.0 (1.0–1.0) 1.0 (1.0–1.0)
Male 0.7 (0.7–0.8) 1.0 (0.9–1.2) 0.8 (0.8–0.9) 1.1 (1.0–1.2) 0.9 (0.8–1.0) 1.0 (0.9–1.1)
Comorbidities
Shock 10.0 (8.4–11.9) 10.4 (8.1–13.4) 8.1 (6.9–9.6) 7.6 (6.0–9.7) 4.8 (4.1–5.7) 4.2 (3.3–5.4)
Diabetes with Complications 1.5 (1.1–2.0) 1.4 (1.0–1.9) 1.5 (1.1–1.9) 1.2 (0.9–1.5) 2.0 (1.6–2.5) 1.5 (1.2–1.9)
Congestive Heart Failure 2.1 (1.9–2.3) 2.2 (1.9–2.4) 2.1 (2.0–2.3) 2.3 (2.1–2.6) 2.7 (2.5–2.9) 2.8 (2.5–3.0)
Cancer 2.2 (1.7–2.8) 2.4 (1.8–3.2) 2.1 (1.7–2.7) 3.1 (2.4–4.1) 3.9 (3.2–4.8) 5.8 (4.6–7.4)
Cerebrovascular disease 3.0 (2.6–3.6) 3.5 (2.8–4.5) 2.6 (2.3–3.1) 3.1 (2.5–3.9) 2.6 (2.2–3.0) 2.6 (2.1–3.2)
Pulmonary Edema 2.6 (1.8–3.8) 2.5 (1.5–4.1) 2.5 (1.7–3.6) 2.9 (1.8–4.5) 2.8 (2.0–3.9) 3.4 (2.2–5.1)
Acute Renal Failure 5.1 (4.2–6.2) 3.1 (2.6–3.8) 4.2 (3.5–5.0) 2.7 (2.3–3.3) 3.5 (2.9–4.3) 2.4 (2.0–2.8)
Chronic Renal Failure 1.9 (1.6–2.4) 1.4 (1.1–1.8) 1.7 (1.4–2.1) 1.7 (1.4–2.1) 2.1 (1.8–2.5) 2.2 (1.8–2.6)
Cardiac Dysrhythmias 2.0 (1.9–2.3) 1.8 (1.6–2.1) 1.8 (1.6–1.9) 1.6 (1.4–1.8) 1.6 (1.5–1.8) 1.5 (1.3–1.6)
Constant 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
C-Statistic (AUC) 0.841 0.826 0.816 0.809 0.815 0.812
Brier Score 0.062 0.055 0.062 0.056 0.074 0.072
R-square 0.224 0.201 0.195 0.182 0.207 0.207
Number of patients 29610 20251 29610 20251 29610 20251
Note: All Odds Ratios (OR) adjust for age, sex, shock, diabetes with complications, congestive heart failure, cancer, cerebrovascular disease, 
pulmonary edema, acute renal failure, chronic renal failure, and cardiac dysrhythmias.BMC Health Services Research 2006, 6:161 http://www.biomedcentral.com/1472-6963/6/161
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demonstrated comparable sensitivity, specificity, PPV and
NPV between ICD-9 and ICD-10 coding algorithms. Evi-
dence that the ICD-10 coding algorithms performed sim-
ilar to past coding algorithms will allow future policy and
quality judgements to be made on AMI outcomes with
accurate ICD-10 comorbidities.
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